- Home
- CAVA vs PEN Comparison
CAVA vs PEN Comparison
Compare CAVA & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAVA
- PEN
- Stock Information
- Founded
- CAVA 2006
- PEN 2004
- Country
- CAVA United States
- PEN United States
- Employees
- CAVA N/A
- PEN N/A
- Industry
- CAVA Restaurants
- PEN Medical/Dental Instruments
- Sector
- CAVA Consumer Discretionary
- PEN Health Care
- Exchange
- CAVA Nasdaq
- PEN Nasdaq
- Market Cap
- CAVA 9.9B
- PEN 10.5B
- IPO Year
- CAVA 2023
- PEN 2015
- Fundamental
- Price
- CAVA $86.00
- PEN $277.35
- Analyst Decision
- CAVA Buy
- PEN Strong Buy
- Analyst Count
- CAVA 14
- PEN 16
- Target Price
- CAVA $124.71
- PEN $290.93
- AVG Volume (30 Days)
- CAVA 4.2M
- PEN 451.5K
- Earning Date
- CAVA 05-27-2025
- PEN 04-23-2025
- Dividend Yield
- CAVA N/A
- PEN N/A
- EPS Growth
- CAVA 423.81
- PEN N/A
- EPS
- CAVA 1.10
- PEN 0.36
- Revenue
- CAVA $963,713,000.00
- PEN $1,194,615,000.00
- Revenue This Year
- CAVA $25.56
- PEN $14.26
- Revenue Next Year
- CAVA $21.07
- PEN $14.21
- P/E Ratio
- CAVA $78.18
- PEN $762.38
- Revenue Growth
- CAVA 32.25
- PEN 12.86
- 52 Week Low
- CAVA $58.22
- PEN $148.00
- 52 Week High
- CAVA $172.43
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- CAVA 47.43
- PEN 53.70
- Support Level
- CAVA $83.35
- PEN $253.27
- Resistance Level
- CAVA $93.25
- PEN $278.39
- Average True Range (ATR)
- CAVA 6.50
- PEN 14.09
- MACD
- CAVA 1.08
- PEN 0.97
- Stochastic Oscillator
- CAVA 68.35
- PEN 90.04
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.